Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

T1G3R-1: ctDNA detectability and prognosis in T1 grade 3 bladder cancer

Observational study of whether ctDNA can be detected in T1 grade 3 urothelial bladder cancer and whether it changes across resection and instillation therapy.

University Hospital, Basel